Sirturo bedaquiline regulatory update

On Dec. 28, 2012, FDA granted accelerated approval to an NDA from Johnson & Johnson for Sirturo bedaquiline to treat adults with multi-drug resistant pulmonary tuberculosis (TB) as part of

Read the full 308 word article

How to gain access

Continue reading with a
two-week free trial.